vs
Side-by-side financial comparison of Coca-Cola Company (The) (KO) and Moolec Science SA (MLEC). Click either name above to swap in a different company.
Coca-Cola Company (The) is the larger business by last-quarter revenue ($11.8B vs $2.6M, roughly 4473.0× Moolec Science SA). Coca-Cola Company (The) runs the higher net margin — 19.2% vs -91.8%, a 111.1% gap on every dollar of revenue.
The Coca-Cola Company is an American multinational corporation founded in 1892 headquartered in Atlanta, Georgia. It manufactures, sells and markets soft drinks including Coca-Cola, other non-alcoholic beverage concentrates and syrups, and alcoholic beverages. Its stock is listed on the New York Stock Exchange and is a component of the DJIA and the S&P 500 and S&P 100 indices.
Moolec Science SA is a global agricultural biotechnology and food technology company specializing in molecular farming. It uses engineered crop platforms to produce sustainable, cost-competitive animal-derived proteins for use in alternative meat, dairy products and food ingredients, serving food manufacturers, agribusinesses and consumer goods brands across North America, Europe and Latin America.
KO vs MLEC — Head-to-Head
Income Statement — Q4 2025 vs Q2 2025
| Metric | | |
|---|---|---|
| Revenue | $11.8B | $2.6M |
| Net Profit | $2.3B | $-2.4M |
| Gross Margin | 60.0% | -25.5% |
| Operating Margin | 15.6% | -77.9% |
| Net Margin | 19.2% | -91.8% |
| Revenue YoY | 2.4% | — |
| Net Profit YoY | 3.5% | — |
| EPS (diluted) | $0.53 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.8B | — | ||
| Q3 25 | $12.5B | — | ||
| Q2 25 | $12.5B | — | ||
| Q1 25 | $11.1B | — | ||
| Q4 24 | $11.5B | $2.6M | ||
| Q3 24 | $11.9B | — | ||
| Q2 24 | $12.4B | — | ||
| Q1 24 | $11.3B | — |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $3.8B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $2.2B | $-2.4M | ||
| Q3 24 | $2.8B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $3.2B | — |
| Q4 25 | 60.0% | — | ||
| Q3 25 | 61.5% | — | ||
| Q2 25 | 62.4% | — | ||
| Q1 25 | 62.6% | — | ||
| Q4 24 | 60.0% | -25.5% | ||
| Q3 24 | 60.7% | — | ||
| Q2 24 | 61.1% | — | ||
| Q1 24 | 62.5% | — |
| Q4 25 | 15.6% | — | ||
| Q3 25 | 32.0% | — | ||
| Q2 25 | 34.1% | — | ||
| Q1 25 | 32.9% | — | ||
| Q4 24 | 23.5% | -77.9% | ||
| Q3 24 | 21.2% | — | ||
| Q2 24 | 21.3% | — | ||
| Q1 24 | 18.9% | — |
| Q4 25 | 19.2% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 30.4% | — | ||
| Q1 25 | 29.9% | — | ||
| Q4 24 | 19.0% | -91.8% | ||
| Q3 24 | 24.0% | — | ||
| Q2 24 | 19.5% | — | ||
| Q1 24 | 28.1% | — |
| Q4 25 | $0.53 | — | ||
| Q3 25 | $0.86 | — | ||
| Q2 25 | $0.88 | — | ||
| Q1 25 | $0.77 | — | ||
| Q4 24 | $0.50 | $-0.06 | ||
| Q3 24 | $0.66 | — | ||
| Q2 24 | $0.56 | — | ||
| Q1 24 | $0.74 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.3B | $1.9M |
| Total DebtLower is stronger | $42.1B | — |
| Stockholders' EquityBook value | $32.2B | $2.8M |
| Total Assets | $104.8B | $31.4M |
| Debt / EquityLower = less leverage | 1.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.3B | — | ||
| Q3 25 | $12.7B | — | ||
| Q2 25 | $9.6B | — | ||
| Q1 25 | $8.4B | — | ||
| Q4 24 | $10.8B | $1.9M | ||
| Q3 24 | $13.9B | — | ||
| Q2 24 | $13.7B | — | ||
| Q1 24 | $10.4B | — |
| Q4 25 | $42.1B | — | ||
| Q3 25 | $43.2B | — | ||
| Q2 25 | $45.0B | — | ||
| Q1 25 | $43.5B | — | ||
| Q4 24 | $42.4B | — | ||
| Q3 24 | $43.0B | — | ||
| Q2 24 | $38.1B | — | ||
| Q1 24 | $36.5B | — |
| Q4 25 | $32.2B | — | ||
| Q3 25 | $31.2B | — | ||
| Q2 25 | $28.6B | — | ||
| Q1 25 | $26.2B | — | ||
| Q4 24 | $24.9B | $2.8M | ||
| Q3 24 | $26.5B | — | ||
| Q2 24 | $25.9B | — | ||
| Q1 24 | $26.4B | — |
| Q4 25 | $104.8B | — | ||
| Q3 25 | $106.0B | — | ||
| Q2 25 | $104.3B | — | ||
| Q1 25 | $101.7B | — | ||
| Q4 24 | $100.5B | $31.4M | ||
| Q3 24 | $106.3B | — | ||
| Q2 24 | $101.2B | — | ||
| Q1 24 | $99.4B | — |
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.38× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.66× | — | ||
| Q4 24 | 1.70× | — | ||
| Q3 24 | 1.62× | — | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 1.38× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.8B | — |
| Free Cash FlowOCF − Capex | $2.9B | — |
| FCF MarginFCF / Revenue | 24.3% | — |
| Capex IntensityCapex / Revenue | 7.5% | 4.4% |
| Cash ConversionOCF / Net Profit | 1.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.3B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8B | — | ||
| Q3 25 | $5.0B | — | ||
| Q2 25 | $3.8B | — | ||
| Q1 25 | $-5.2B | — | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $-1.3B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $528.0M | — |
| Q4 25 | $2.9B | — | ||
| Q3 25 | $4.6B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $-5.5B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $-1.7B | — | ||
| Q2 24 | $3.2B | — | ||
| Q1 24 | $158.0M | — |
| Q4 25 | 24.3% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 26.9% | — | ||
| Q1 25 | -49.5% | — | ||
| Q4 24 | 27.3% | — | ||
| Q3 24 | -14.6% | — | ||
| Q2 24 | 25.6% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 7.5% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 7.0% | 4.4% | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 3.3% | — |
| Q4 25 | 1.65× | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | -1.56× | — | ||
| Q4 24 | 1.80× | — | ||
| Q3 24 | -0.44× | — | ||
| Q2 24 | 1.49× | — | ||
| Q1 24 | 0.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KO
| Other | $7.0B | 59% |
| Finished Product Operations | $2.4B | 21% |
| Concentrate Operations | $2.4B | 20% |
MLEC
Segment breakdown not available.
